SONOSCAPE(SZ:300633) Sou Hu Cai Jing·2026-02-13 13:05Core Viewpoint - The stock of Kaili Medical (300633) has shown a decline in price and mixed capital flow, indicating potential volatility in investor sentiment and market performance [1][2]. Group 1: Stock Performance - As of February 13, 2026, Kaili Medical's stock closed at 26.6 yuan, down 1.04% with a turnover rate of 0.48% and a trading volume of 20,900 lots, amounting to a transaction value of 56.07 million yuan [1]. - Over the past five days, the stock has experienced fluctuations, with a notable drop on February 13, where the main capital saw a net outflow of 224.51 million yuan, accounting for 4.0% of the total transaction value [2]. Group 2: Financial Metrics - Kaili Medical's total market capitalization is 11.51 billion yuan, slightly above the industry average of 10.91 billion yuan, ranking 30th out of 129 companies in the medical device sector [3]. - The company reported a net profit of 33.51 million yuan, which is significantly lower than the industry average net profit of 208 million yuan, placing it 79th in the industry ranking [3]. - The company's gross margin stands at 60.36%, which is higher than the industry average of 51.01%, indicating a strong pricing power in its products [3]. Group 3: Recent Financial Performance - For the first three quarters of 2025, Kaili Medical's main revenue reached 1.459 billion yuan, reflecting a year-on-year increase of 4.37%, while the net profit decreased by 69.25% to 33.51 million yuan [3]. - In the third quarter of 2025, the company achieved a quarterly revenue of 495 million yuan, up 28.42% year-on-year, but reported a negative net profit of -13.52 million yuan, despite a year-on-year increase of 78.05% [3]. Group 4: Analyst Ratings - In the last 90 days, four institutions have provided ratings for Kaili Medical, with three giving a "buy" rating and one an "accumulate" rating, indicating a generally positive outlook from analysts [4].